Disease-specific growth charts capture characteristic growth patterns in children with PMM2 - CDG. [PDF]
Sarafoglou K +16 more
europepmc +1 more source
A liposomal carbohydrate vaccine, adjuvanted with an NKT cell agonist, induces rapid and enhanced immune responses and antibody class switching. [PDF]
Jia JX +6 more
europepmc +1 more source
Investigation of the Clinical and Genetic Spectrum of PMM2-CDG: Insights from a Family with a Novel Variant and Previous Studies. [PDF]
Alagha P +6 more
europepmc +1 more source
Interplay of Impaired Cellular Bioenergetics and Autophagy in PMM2-CDG. [PDF]
Ligezka AN +12 more
europepmc +1 more source
Goal attainment in PMM2-CDG: A new approach measuring meaningful clinical outcomes. [PDF]
Verberkmoes S +15 more
europepmc +1 more source
Hyperinsulinism May Be Underreported in Hypoglycemic Patients with Phosphomannomutase 2 Deficiency [PDF]
Vurallı D +7 more
europepmc +1 more source
Phosphomannomutase 1 restrains adipose thermogenic programming via inosine signaling. [PDF]
Ye Y +9 more
europepmc +1 more source
Cysteine Pathogenic Variants of PMM2 Are Sensitive to Environmental Stress with Loss of Structural Stability. [PDF]
Yu F +9 more
europepmc +1 more source
Causes of mortality in the congenital disorders of glycosylation. [PDF]
Alharbi H +7 more
europepmc +1 more source
<i>In Silico</i> Analysis of Phosphomannomutase-2 Dimer Interface Stability and Heterodimerization with Phosphomannomutase-1. [PDF]
Hay Mele B +4 more
europepmc +1 more source

